# John Kauh

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/john-kauh/

## Facts

| Field | Value |
| --- | --- |
| Citations | 12,108 |
| Field | Hepatocellular Carcinoma Treatment and Prognosis |
| h-index | 32 |
| i10-index | 69 |
| Last Known Institution | Houston Methodist Sugar Land Hospital |
| OpenAlex ID | https://openalex.org/A5055989413 |
| ORCID iD | 0000-0002-4359-7383 |
| Works | 196 |

## Researcher papers

- [Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer](https://scholariq.org/papers/safety-and-activity-of-anti-pd-l1-antibody-in-patients-with-advanced-cancer/)

## Researcher topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.